A
PRCT icon

AlphaQuest’s Procept Biorobotics PRCT Stock Holding History

AlphaQuest’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-711
Closed -$22.4K – 1550
2025
Q4 		$22.4K Sell
711
-12,686
-95% -$421K ﹤0.01% 2084
2025
Q3 		$478K Buy
13,397
+12,307
+1,129% +$562K 0.03% 818
2025
Q2 		$62.8K Buy
1,090
+1,010
+1,263% +$57.1K 0.01% 1569
2025
Q1 		$4.66K Buy
+80
New +$5.46K ﹤0.01% 1866
2024
Q4 		– Sell
-12
Closed -$961 – 1945
2024
Q3 		$961 Sell
12
-662
-98% -$47K ﹤0.01% 1620
2024
Q2 		$41.2K Buy
674
+648
+2,492% +$38.5K 0.01% 1109
2024
Q1 		$1.28K Buy
+26
New +$1.24K ﹤0.01% 1249

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AlphaQuest's PRCT Position: Q1 2026 in Review

AlphaQuest sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 711 shares — an estimated $22.4K sold.

AlphaQuest first reported a position in PRCT in Q1 2024 and held it in 7 quarters. The position peaked at $478K in Q3 2025. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • AlphaQuest reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 711 Procept Biorobotics shares in Q1 2026, an estimated $22.4K.
  • AlphaQuest first reported a position in Procept Biorobotics in Q1 2024 and held it in 7 quarters.
  • AlphaQuest's Procept Biorobotics position peaked at $478K in Q3 2025.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.